47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
49.41.Z - Road freight transport
62.02.Z - Activities related to programming, IT consulting, and related activities
68.20.Z - Rental and management of own or leased real estate
73.11.Z - Advertising agency activities
2022 | 2023 | 2024 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0 | -0,1 | -0,1 | -3,6 |
EBITDA | 0 | -0,1 | -0,1 | -3,5 |
Short time liabilities | 2,2 | 2,3 | 2,6 | 10,8 |
Equity capital | 0,8 | 0,7 | 0,6 | -8,8 |
Operating profit (EBIT) | 0 | -0,1 | -0,1 | -3,5 |
Assets | 3 | 3 | 3,2 | 6,2 |
Net profit (loss) | 0 | -0,1 | -0,1 | -3,6 |
Cash | 1,3 | 1,2 | 1,4 | 17,3 |
Liabilities and provisions for liabilities | 2,2 | 2,3 | 2,6 | 10,8 |
Net income from sale | 11,1 | 11,5 | 12,1 | 5 |
Working assets | 3 | 3 | 3,2 | 6,2 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 3,7 | -8,5 | -9,7 | -1,2 |
Equity capital to total assets | 25,9 | 23,3 | 20 | -3,3 |
Gross profit margin | 0,3 | -0,5 | -0,5 | 0 |
EBITDA Margin | 0,3 | -0,5 | -0,5 | 0 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 73 | 74 | 78 | 4 |
Current financial liquidity indicator | 1.3489434719085693 | 1.3036534786224365 | 1.2499961853027344 | -0,1 |
Net dept to EBITDA | 18.728925704956055 | -13.990097045898438 | -13.605984687805176 | 0,4 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane